Eledon Pharmaceuticals (NASDAQ:ELDN) completed enrollment of its phase 2 BESTOW trial using its immunosuppressive drug tegoprubart for the prevention of organ rejection in patients who undergo ...

Research from Radboud university medical center reveals that T cells from the adaptive immune system can manipulate the memory of innate immune cells. Previously, it was believed that the memory ...

Drug firm Lupin on Wednesday said it has launched generic immunosuppressant Tacrolimus capsules in the American market after its alliance partner Concord Biotech received approval for the product ...

The first CI used in transplantation, CsA, was approved by the US Food and Drug Administration in 1983. CsA was rapidly adopted into immunosuppressive regimens. The results of early pivotal ...

Type 1 diabetes develops when the body destroys its own insulin-producing cells. Using stem cells to replace them could be a ...